Ghent (1)

Safety Markers of Adjuvanted Influenza Vaccine (1)

Completed (1)

phase 4 (1)

University Hospital, Ghent (1)

GlaxoSmithKline (1)

Innovative Medicines Initiative (1)

Max Planck Institute for Infection Biology (1)

Novartis Vaccines (1)

University of Surrey (1)

VisMederi srl (1)

deCODE genetics (1)

fluad (1)

saline (1)

biological (1)

Other (1)

Interventional (1)

safety markers of adjuvanted influenza vaccine

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Dec 19, 2022